Company Overview

ViewRay® Inc., (NASDAQ:VRAY), designs, manufactures and markets MRIdian® the world’s first MRI-guided radiation therapy system that can image and treat cancer patients simultaneously. MRIdian addresses key limitations of existing external-beam radiation therapy technologies because it integrates MRI technology, radiation delivery, and proprietary software to locate, target, and track the position and shape of soft-tissue tumors while radiation is delivered. Real-time MRI-imaging clearly defines the targeted tumor from the surrounding soft tissue and other critical organs during radiation treatment allowing the system to deliver radiation to the tumor accurately while delivering less radiation to healthy tissue. MRIdian’s targeting accuracy combined with improved tumor visibility and accurate dose recording means clinicians can treat patients who may not previously have been considered radiation therapy candidates. ViewRay believes MRIdian may improve the safety and efficacy of radiation therapy, potentially leading to improved patient outcomes with reduced side-effects from off-target radiation delivery.

Financial News

Date Title and Summary Additional Formats
Toggle Summary Baptist Health South Florida to Acquire a Second ViewRay MRIdian® MR-Guided Radiation Therapy System
Eugene M. & Christine E. Lynn Cancer Institute to deliver on its continued commitment to excellence and innovation in cancer care, as one of only three locations in S. Florida offering patients this novel cancer-fighting technology CLEVELAND , Oct. 22, 2021 /PRNewswire/ -- ViewRay, Inc.
Toggle Summary ViewRay to Host a Virtual Clinical Data Event for Investors and Analysts on October 28, 2021
CLEVELAND , Oct. 18, 2021 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today that the company will host a Virtual Clinical Data Event for Investors and Analysts on Thursday, October 28, 2021 . The event will begin at 8:30 am ET / 5:30 am PT .
Toggle Summary ViewRay Announces Conference Call for Third Quarter 2021 Financial Results to be Held After Market on November 4, 2021
CLEVELAND , Oct. 14, 2021 /PRNewswire/ --  ViewRay, Inc. (Nasdaq: VRAY) announced today details relating to the release of its third quarter 2021 financial results. ViewRay will hold a conference call to discuss results on Thursday, November 4, 2021 at 4:30 p.m. ET / 1:30 p.m. PT .
Toggle Summary ViewRay Announces 510(k) Pending Status of the Newest Generation of MRIdian Innovations
New suite of workflow and clinical features to be highlighted at upcoming ASTRO 2021 conference CLEVELAND , Sept. 29, 2021 /PRNewswire/ --  ViewRay, Inc. (NASDAQ: VRAY) today announced that the company has received acceptance from the FDA on their recent submission for new MRIdian features focused

Stock Quote

Data Provided by Refinitiv. Minimum 15 minutes delayed.

E-mail Alerts

Alerts are e-mailed to you whenever certain new company information is posted to this site. Sign-up Now!
Click here for E-mail Alerts

Transfer Agent
American Stock Transfer & Trust Company, LLC
6201 15th Avenue
Brooklyn, NY 11219
(800) 937-5449

In Need of Customer Support? Contact

  Language Select